Published by Josh White on 16th April 2024
(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).
URL: http://www.digitallook.com/dl/news/story/34224266/...